Erythema nodosum is a common skin condition characterized by painful, reddish-purple lumps that appear on the shins and lower legs. The lumps can range in size from a few millimeters to several centimeters and may be accompanied by fever, joint pain, and swollen lymph nodes. Although the condition is usually self-limiting and resolves without treatment, it can be quite uncomfortable and cause significant disruption to an individual’s life. In this comprehensive guide, we will explore the causes, diagnosis, and treatment of erythema nodosum.
Erythema nodosum is an inflammatory disorder of the subcutaneous fat that affects the lower legs and shins. It is characterized by tender, reddish-purple lumps that can range in size from a few millimeters to several centimeters. The condition is usually self-limiting and resolves without treatment, but it can be quite uncomfortable and cause significant disruption to an individual’s life.
The exact cause of erythema nodosum is unknown, but it is thought to be an immune system reaction to certain triggers. Common triggers include certain medications, infections, and inflammatory diseases. Other possible causes include pregnancy, sarcoidosis, inflammatory bowel disease, and Behcet’s disease.
The diagnosis of erythema nodosum is usually based on the physical examination of the affected area. The condition is usually easily recognizable due to the presence of tender, reddish-purple lumps. In some cases, a biopsy may be performed to confirm the diagnosis. Blood tests may also be performed to look for signs of infection or other underlying conditions.
The treatment for erythema nodosum depends on the underlying cause. In cases where the condition is caused by an infection or an underlying medical condition, the underlying cause must be treated in order to resolve the erythema nodosum. In cases where the cause is unknown or the condition is self-limiting, treatment is usually focused on relieving the symptoms. Common treatments include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and antibiotics.
The best way to prevent erythema nodosum is to avoid known triggers, such as certain medications, infections, and inflammatory diseases. It is also important to practice good hygiene and to get regular check-ups to identify any underlying medical conditions.
Erythema nodosum is a common skin condition characterized by painful, reddish-purple lumps that appear on the shins and lower legs. The exact cause of the condition is unknown, but it is thought to be an immune system reaction to certain triggers. The diagnosis is usually based on the physical examination of the affected area and treatment is usually focused on relieving the symptoms. In some cases, treatment of the underlying cause may be necessary. The best way to prevent erythema nodosum is to avoid known triggers and to practice good hygiene.
1.
Potential new therapy for childhood brain cancer could heal treatment-resistant tumors
2.
Investigating the Relationship Between GERD and Anxiety/Depression.
3.
In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.
4.
Indoor hydroponic gardening can improve mental health and quality of life for cancer patients
5.
Dr. Prerana S. Nesargi's message for Childhood Cancer Awareness Month 2023 is to increase understanding of pediatric oncology.
1.
How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care?
2.
Value, Access, and Affordability in Next-Gen Oncology: Navigating Costs, Coverage, and Clinical Impact
3.
Vaccines that can help prevent cancer
4.
Innovative Strategies in Prostate Cancer Management: From Surveillance to Systemic Therapies
5.
Revolutionizing Cancer Treatment: Harnessing the Power of AI in Histopathology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
2.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
4.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
5.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation